Patents by Inventor Christopher G. Smith

Christopher G. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240290489
    Abstract: The present invention provides a computer-implemented method for analysing a urine sample from a subject. The method comprises providing the value of one or more cell-free DNA fragment size metrics for said sample, and determining whether the sample has a high or low likelihood of being from a brain cancer patient by providing said values of said cell-free DNA fragment size metrics as input to a machine learning model. The machine learning model is trained to classify sample data into one of at least two classes, the at least two classes comprising a first class having a high likelihood of being from a brain cancer patient and a second class having a low likelihood of being from a brain cancer patient. Methods for diagnosing or screening for brain cancer, detecting recurrence or residual disease, providing a prognosis or selecting a treatment for brain cancer are also described.
    Type: Application
    Filed: July 8, 2022
    Publication date: August 29, 2024
    Applicants: Cambridge Enterprise Limited, Stichting Amsterdam UMC
    Inventors: Kevin Brindle, Richard Mair, Florent Moulière, Nitzan Rosenfeld, Christopher G. Smith
  • Publication number: 20200402613
    Abstract: The present invention provides a computer-implemented method for detecting cell-free DNA (cfDNA), such as circulating tumour DNA, in a DNA-containing sample obtained from a patient, the method comprising: (a) providing loci of interest comprising at least 2 mutation-containing loci representative of a tumour of the patient (“patient-specific loci”); (b) providing sequence data comprising sequence reads of a plurality of polynucleotide fragments from a DNA-containing sample from the patient, wherein said sequence reads span said at least 2 mutation-containing loci of step (a); (c) optionally, performing reads collapsing to group the sequence reads into read families; (d) calculating the mutant allele fraction across some or all of said at least 2 patient-specific loci, optionally wherein the mutant allele fraction is calculated by aggregating mutant reads and total reads; (e) classifying the sample as containing or not containing the target cfDNA based on the calculated mutant allele fraction.
    Type: Application
    Filed: March 6, 2019
    Publication date: December 24, 2020
    Inventors: Eyal Fisher, Katrin Heider, Charles Massie, Florent Mouliere, Nitzan Rosenfeld, Christopher G. Smith, Jonathan C.M. Wan
  • Patent number: 7765133
    Abstract: A system for facilitating the processing and settlement of a securities trade is provided. The system includes a computer which receives trade execution information indicative of an executed trade by a first trading party and trade allocation information indicative of an executed trade by a second trading party. The system also includes a database of trading party profiles accessible by the computer, the trading party profiles being indicative of acceptable trade parameters for each trading party. Executing on the computer is a matching program for comparing the trade execution information with the trade allocation information and for determining that a match exists if the trade execution information and the trade allocation information correlate within the acceptable trade parameters supplied in the trading party profiles for the first trading party and the second trading party.
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: July 27, 2010
    Assignee: Omgeo LLC
    Inventors: P. Howard Edelstein, Christopher J. Walsh, Christopher G. Smith, Gary S. Foster, Peter J. Tierney
  • Publication number: 20030029455
    Abstract: An apparatus and method, as embodied and broadly described herein, provide a respiratory mask for the application of positive pressure to the airways of a patient. The mask includes two chambers in which a first chamber is maintained with positive pressure with respect to the ambient pressure and contains a first opening which, when in use, is positioned against the patient's face. A second chamber, maintained at negative pressure with respect to the ambient pressure, contains a second opening which, when in use, is positioned against the patient's face, such that the face contacting area of the first opening is smaller than the face contacting area of the second opening.
    Type: Application
    Filed: April 3, 2001
    Publication date: February 13, 2003
    Inventors: Christopher G. Smith, Patrick J. McAuliffe
  • Patent number: 4508856
    Abstract: Polymers that are stable under aqueous conditions of high ionic strength are combined with non-fused, silicate based microspheres that are modified with multivalent metals but not washed or dried, said microspheres being present as filters.
    Type: Grant
    Filed: October 28, 1983
    Date of Patent: April 2, 1985
    Assignee: PQ Corporation
    Inventors: Christopher G. Smith, John F. Peters
  • Patent number: D464816
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: October 29, 2002
    Assignee: KI-ADD Specialized Support Technology, Inc.
    Inventors: Roger K. Leib, Christopher G. Smith